GLOBALT Investments LLC / GA 13F: Adds $1.5M to CL Stake
Key Points
- GLOBALT Investments increased its holdings in Colgate-Palmolive by 18,061 shares, a 57.4% rise, now holding 49,546 shares worth about $4.2 million.
- The stock closed at $92.17 on October 27, 2026, and has recently traded around $92.19, almost equal to its event closing price.
- Colgate-Palmolive has a market cap of around $74.2 billion, with a P/E ratio of 36.7 and a dividend yield of 2.28%.
Get Colgate-Palmolive Company text alerts
We text you when insiders, Congress, analysts or big funds move on $CL.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Colgate-Palmolive Company alert may contain errors. Disclosures
On October 27, 2026, GLOBALT Investments LLC boosted its stake in Colgate-Palmolive Company (CL) by 18,061 shares, bringing its total to 49,546 shares valued at approximately $4.2 million. This information comes from the fund's latest Form 13F filing with the SEC.
GLOBALT's reported value in Colgate-Palmolive now stands at about $1.68 billion. With this increase, the company now represents 0.25% of GLOBALT's overall portfolio, ranking 34th among its 212 holdings. The change in shares reflects a 57.4% increase from the previous count of 31,485 shares.
CL
Colgate-Palmolive Company
Other Institutional Activity in Colgate-Palmolive
Vanguard Asset Management holds 1,603,022 shares of Colgate-Palmolive, maintaining its position without any changes. Sequoia Financial Advisors increased its stake by 10,434 shares, now holding 64,773 shares valued at about $5.9 million. In contrast, Intech Investment Management reduced its holdings by 113,364 shares, now owning 278,568 shares worth approximately $25.5 million.
Colgate-Palmolive Company Stock Down 2.0%
Colgate-Palmolive shares closed at $92.17 on October 27, 2026, and have recently traded around $92.19. The stock is currently above its 50-day moving average by about 3.2%, but it is still below its 52-week high of $99.33 by 7.2%. The mean price target for the stock is $98.15, suggesting it trades below that level by about 6.1%.
Recent Earnings
Colgate-Palmolive reported trailing twelve-month revenue of approximately $21.0 billion, with an EPS of $2.54. The next earnings report is scheduled for October 30, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
4 analysts raised price targets.
-
EPS & revenue
EPS met estimates. Revenue missed estimates by 0.9%.
-
Profit surprise
EBITDA missed by 15 percent. Operating income missed by 17 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
4 target raises.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Colgate delivered a solid first quarter with accelerating volume growth, especially in emerging markets and the Hill's pet food business, which grew nearly 5 percent. However, North America oral care remains weak and the company faces significant pressure from rising costs in resins, petrochemicals, and oils, which are expected to be up more than 20 percent year over year. Management is confident in its ability to maintain earnings growth through pricing, innovation, and efficiency programs while continuing to invest in brands.
Guidance The company reaffirmed full year earnings growth in the low to mid single digits. They expect gross margins to decline due to about $300 million in additional raw material and logistics costs tied to oil prices around $110 per barrel. They plan to offset inflation through revenue growth management, innovation, and a $200 million to $300 million cost savings program.
Fine but not compelling. Acceptable results that likely do not create a meaningful forward reset.
Insider Buying and Selling at Colgate-Palmolive Company
Several insiders have recently sold shares of Colgate-Palmolive. Gregory Malcolm, an officer, sold 2,300 shares on May 15, 2026, at an average price of $88.44, totaling approximately $203,412. CEO Noel R. Wallace sold 322,042 shares on August 5, 2026, valued at around $29.7 million. Other sales include John T. Cahill, who sold 4,170 shares at $93.37, and Panagiotis Tsourapas, who sold 10,000 shares at $92.05.
Analysts Set New Price Targets
On October 19, 2026, JP Morgan maintained its "Overweight" rating for Colgate-Palmolive with a price target of $104. Earlier, UBS also maintained a "Buy" rating, raising its target to $109. The consensus recommendation for the stock is "buy," with a mean price target of $98.15 based on 20 analyst opinions.
About Colgate-Palmolive
Colgate-Palmolive Company manufactures and sells consumer products, including oral and personal care items, as well as pet nutrition products. The company's strong market presence in the consumer defensive sector makes it a key player in household and personal products.
Bottom Line
Investors should keep an eye on Colgate-Palmolive's upcoming earnings report on October 30, 2026, and watch for further filings from GLOBALT Investments. The recent boost in their stake indicates continued confidence in the company's performance.
Related Filing Alerts
Source: GLOBALT Investments LLC / GA's 13F filing on $CL (Oct 27, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts